copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Home | Global Trial Finder What is a Clinical Trial? A clinical trial, also called a research study, is a scientific evaluation that helps medical professionals learn about an investigational medication or vaccine But there’s much more to a clinical trial than just that To find out what we mean, watch this short video that will: • Describe a clinical trial in more detail • Explain investigational medication
A Study of Amivantamab Alone or in Addition to Other . . . - Janssen The purpose of this study is to determine safety and preliminary efficacy of amivantamab monotherapy, amivantamab in addition to pembrolizumab, amivantamab in addition to paclitaxel and amivantamab in addition to pembrolizumab and carboplatin in participants with recurrent metastatic head and neck cancer The study will also confirm the recommended Phase 2 combination dose (RP2CD) for
A Phase 1 2 Study of Bleximenib in Participants With Acute Leukemia The purpose of this study is to determine the recommended Phase 2 dose (s) (RP2D [s]) of bleximenib in phase 1 (Part 1 [Dose Escalation] and to determine the safety and tolerability at RP2D in Phase 1 Part 2 (Dose expansion) The purpose of the Phase 2 part of the study is to evaluate the efficacy of bleximenib at the RP2D
A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid . . . The purpose of Part 1 (Dose Escalation) of the study is to assess the safety and tolerability, and to identify the recommended Phase 2 dose [s] (RP2D [s]) in participants with relapsed or refractory (R R) acute myeloid leukemia (AML) (that is a type of blood cancer that has come back after treatment or has stopped responding to treatment) or R R higher-risk type of myelodysplastic neoplasms
Nipocalimab in Moderate to Severe Sjogrens Disease (DAFFODIL) This clinical development program for nipocalimab in SjD includes 2 identical double blind, placebo-controlled studies to evaluate the efficacy, safety, and tolerability of nipocalimab in participants greater than or equal to (>=) 18 years of age with moderate to severe SjD